According to Vision Research Reports, the global epilepsy monitoring devices market size was valued at US$ 540 Mn in 2019 and to reach valuation over US$ 920 million by 2028 with a CAGR of 6.1% during the forecast period from 2021 to 2028.
Rise in the prevalence of epilepsy, and increase in incidence of head injuries, brain cancer, infections, and substance abuse are anticipated to drive the global epilepsy monitoring devices market.
Epilepsy is a non-communicable chronic brain disease, and affects people of all ages. It causes recurring seizures, which are short episodes of involuntary movement. According to the WHO, single seizure occurrence is not considered as a sign of epilepsy (approximately 10% of people worldwide have one seizure during their lifetime). Epilepsy is defined as having two or more unprovoked seizures. According to NCBI, brain tumor is a common cause of epilepsy, second only to cerebrovascular disease in the geriatric population, accounting for nearly 10% to 30% of all the causes of geriatric epilepsy. Epilepsy is a common manifestation in patients who have brain tumors. Seizures are the onset symptom in 20% to 40% patients with brain tumor; 20% to 45% of patients are likely to suffer from epileptic seizures during the course of the disease.
In terms of product, the conventional devices segment a held major share of the global epilepsy monitoring devices market in 2020. This segment is likely to maintain its dominance during the forecast period. The wearable devices segment is projected to gain market share by 2028. Technological advancements in wearable technology, coupled with rise in the popularity of wearable devices across the globe, are expected to drive the segment. Wearable epilepsy monitoring devices such as Empatica’s Embrace not only provide 24-hour surveillance for epilepsy episodes in patients but can also raise an alarm by sending a message or even make a call immediately to the caregiver in case of emergency.
Based on end user, the hospitals & clinics segment accounted for a major share of the global epilepsy monitoring devices market. This segment is projected to grow at a moderate CAGR during the forecast period. The home care settings segment is expected to gain market share by 2028. Increase in patient affordability and awareness is likely to drive the segment during the forecast period. The hospitals & clinics segment is projected to be the most attractive segment during the forecast period. Hospitals & clinics are the largest users of EEG monitoring and emergency medical services. The segment is anticipated to offer lucrative opportunities, especially in developing countries.
Global Epilepsy Monitoring Devices Market: Prominent Regions
North America held a major share of the global epilepsy monitoring devices market in 2020. Major epilepsy monitoring device providers are domiciled in North America (primarily in the U.S.), which results in large revenue contribution to the epilepsy monitoring devices market. Well-established healthcare infrastructure, high health care expenditure, and high rate of diagnosis in the region are projected to fuel the growth of the epilepsy monitoring devices market in North America.
Europe held the second-largest share of the global epilepsy monitoring devices market in 2020. Major markets in Europe include Germany, France, the U.K., Spain, and Italy. The region is projected to be the most lucrative market for epilepsy monitoring devices during the forecast period, due to high prevalence and diagnosis rates, and high per capita healthcare expenditure.
Asia Pacific accounted for a significant share of the global epilepsy monitoring devices market in 2020, and the market in the region is expected to grow at rapid pace during the forecast period. Major markets in Asia Pacific include Australia & New Zealand, India, China, and Japan. Asia Pacific has been experiencing gradual adoption of new epilepsy monitoring technologies, increase in healthcare expenditure, and changing dynamics of the healthcare industry. These factors are leading to adoption of new technologies by hospitals and home care settings. Increase in the focus of key players and rise in patient volumes are boosting the demand for high-throughput devices in the region. Flexible financial support from manufacturers and distributors in the form of rental agreements is also increasing in the region.
Advances in Wearable Technology Show Promise in Preventing Epileptic Seizures
Seizure symptoms could wary from patient to patient. While some patients may lose control and blankly stare for a few seconds, others may move their arms and legs repeatedly during a seizure. Although there is no concrete solution to stop a seizure when it occurs, rapid progress in wearable epileptic device technology has garnered significant popularity in the past few years. Wearable epileptic devices notify a patient about the possibility of a seizure in advance - a major factor that is expected to influence the adoption of these devices in the near future.
Research & development activities pertaining to the use of wearable epilepsy monitoring devices are in full swing, particularly in developed regions such as North America and Europe - two regions with robust healthcare facilities and infrastructure. For instance, researchers from the Universities of Trieste, Strasbourg, Manchester, and International School for Advanced Studies, Italy, revealed that, minute flakes of graphene have the potential of stopping epileptic seizures. The team of researchers further elaborated on how graphene flakes interfere with the signal at excitatory neuronal synaptic junctions, and thereby prevent seizures.
Manufacturers Developing Monitoring Devices to Reduce SUDEP Cases
Manufacturers operating in the epilepsy monitoring devices market are highly inclined toward offering solutions that would reduce the number of sudden unexpected deaths in epilepsy cases, worldwide. At present, SUDEP poses as a major threat, and is a cause of concern for patients suffering from neurological problems that cannot be treated using medication. Furthermore, within this population, mal seizures, also known as tonic-clonic seizures, is a major concern, as it could lead to muscle contractions and loss of consciousness - two symptoms linked with SUDEP, especially when the patient is alone.
However, to address this problem, several companies are engaged in the development of efficient epilepsy monitoring devices. For instance, Empatica launched a wearable epilepsy monitoring device, Embrace, to ensure that a patient would receive immediate care, post seizure. Further, the device sends an alert to the patient and his/her caretaker when the sensors detect a pattern that indicates the possibility of a seizure. The device was cleared by the FDA in 2018 for use in adults. Trends within the pediatric medical device development space suggest that, acceptance for pediatric devices could potentially decade around 5-10 years. However, Empatica received FDA clearance within 12 months - providing a significant boost to the adoption of wearable epilepsy monitoring devices, and indirectly aiding the growth of the global epilepsy monitoring devices market.
Diagnostic Challenges to Hamper Global Epilepsy Monitoring Devices Market
Key players are expanding their footprints to strengthen their position in the global epilepsy monitoring devices market. Increase in the number of patient population and rise in incidence of head injuries, brain cancer, infections, and substance abuse offer lucrative opportunities to key players to increase their share in the epilepsy monitoring devices market. Manufacturers are engaging in strategic acquisitions, collaborations, and distribution to expand their market share in the global epilepsy monitoring devices market.
Prominent players operating in the global epilepsy monitoring devices market include Compumedics Limited, Empatica, Inc., Masimo Corporation, PulseGuard International Ltd., Koninklijke Philips N.V., Medtronic plc, Natus Medical Incorporated, and Nihon Kohden Corporation.
Epilepsy Monitoring Devices Market by Product
Epilepsy Monitoring Devices Market by End User
Epilepsy Monitoring Devices Market Region
Scope of the Report
VRR’s report on the global epilepsy monitoring devices market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2021 to 2028. The report provides the overall market revenue of the global epilepsy monitoring devices market for the period of 2017–2028, with 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global epilepsy monitoring devices market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of the research efforts, wherein, analysts carry out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global epilepsy monitoring devices market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various phenomena in the global epilepsy monitoring devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global epilepsy monitoring devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global epilepsy monitoring devices market.
The report delves into the competition landscape of the global epilepsy monitoring devices market. Key players operating in the global epilepsy monitoring devices market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of the players in the global epilepsy monitoring devices market that have been profiled in this report.
Key Questions Answered in Epilepsy Monitoring Devices Market Report
A unique research methodology has been utilized by VRR to conduct a comprehensive research on the growth of the global epilepsy monitoring devices market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global epilepsy monitoring devices market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of VRR’s study on the epilepsy monitoring devices market, as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from epilepsy monitoring devices market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global epilepsy monitoring devices market with accuracy. The study also uses the top-down approach to assess the numbers for each segment, and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on the future prospects of the global epilepsy monitoring devices market more reliably and accurately.
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Respiratory Virus Infection Drugs Market (By Drug Type: Cough Suppressants, Antibiotics, Non-Steroidal Anti-Inflammatory Drugs [NSAIDS], Nasal Decongestants, and Others; By Infection Type, By Route of Administration, By Mode of Purchase, By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...